What was the followup rate in the Allergan Core Study on INAMED® Silicone-Filled Breast Implants?

The Allergan Core Study on INAMED® Silicone-Filled Breast Implants has divulged an overall risk for any given complication over the first four years of 41% in primary breast silicone augmentation patients, and 57% for revision-augmentation patients. Of the 455 primary silicone breast augmentation patients enrolled in the study, 83% followed up (378 patients). Of the 147 primary silicone breast augmentation patients enrolled in the study, 83% followed up (378 patients). Of the 147 silicone breast reconstruction patients enrolled in the study, 82% followed up (121 patients).